Marshall Wace »

Outlook Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-12-31 $472k 299k 1.58
2025-06-30 $41k 26k 1.60

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Vanguard S&p 500 Etp (VOO)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-a Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Adv Micro Device Equity Option Call Option (AMD)
Meta Platforms-a Common Stock (META)
Walmart Common Stock (WMT)
Tesla Common Stock (TSLA)
Alphabet Inc-c Common Stock (GOOG)
Circle Internet Common Stock (CRCL)

View all positions for Marshall Wace

Top funds holding Outlook Therapeutics

Schonfeld Strategic Advisors
Vanguard Group
Susquehanna International
BlackRock
Geode Capital Management
Marshall Wace
UBS Group
Millennium Management
State Street Corporation
Jane Street
Commonwealth Equity Services
Simplex Trading
ADAR1 Capital Management
Scotia Capital
Northern Trust

View all funds holding Outlook Therapeutics